Multivariate analysis conducted in the present study indicated that ERβ, HER-2, tumor size, lymph node metastasis, postoperative chemotherapy, radiotherapy and endocrine therapy are independent prognostic factors (P<0.05). The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.